The Research Report Consist of 154 pages, which covers Global Viral Inactivation Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.
Also, the Research report on Viral Inactivation Market covers key statistics for the upcoming forecast year. This Research Report will be the big source of guidance to business leaders, strategy heads.
Viral Inactivation Market by testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.
The Global Viral Inactivation Market poised to grow at a CAGR of 12.3%, to reach $ 573.0
The Global Market segmented into method, product, application, end user, and geography. The method segments included in the report are solvent detergent method, pasteurization, and other methods. Other Viral Inactivation method includes low pH, microwave heating, irradiation, and high-energy light.
Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this Viral Inactivation Market during the forecast period.
Get 10% Customization on Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=121427017
The pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
Major players in the viral inactivation market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).